T5770 |
Alisol B
|
18649-93-9
|
98%
|
|
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol...
|
T9917 |
Denosumab
|
615258-40-7
|
98%
|
|
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand
|
T5720 |
Boldine
|
476-70-0
|
98%
|
|
Boldine is a natual product .Boldine displays anti-cancer, cytoprotective , anti-oxidant and anti-inflammatory activities.
|
T61531 |
NFATc1-IN-1
|
1912422-56-0
|
98%
|
|
NFATc1-IN-1 (also known as compound A04) is a highly effective inhibitor of osteoclast formation induced by RANKL, with an IC50 of 1.57 μM. It exerts its anti-os...
|